Day: May 8, 2025

Yili Reports FY2024 Revenue of 115.8 Billion Yuan, Reinforcing Its Position as Asia’s Leading Dairy Company

HOHHOT, China, May 08, 2025 (GLOBE NEWSWIRE) — On April 29, Inner Mongolia Yili Industrial Group Co., Ltd. (600887.SH) released its financial results, reporting total revenue of 115.78 billion yuan in FY2024, further solidifying its position as Asia’s top dairy producer. In the first quarter of FY2025, Yili delivered better-than-expected growth, achieving simultaneous increases in both […]

Continue Reading

Yili Reports FY2024 Revenue of 115.8 Billion Yuan, Reinforcing Its Position as Asia’s Leading Dairy Company

HOHHOT, China, May 08, 2025 (GLOBE NEWSWIRE) — On April 29, Inner Mongolia Yili Industrial Group Co., Ltd. (600887.SH) released its financial results, reporting total revenue of 115.78 billion yuan in FY2024, further solidifying its position as Asia’s top dairy producer. In the first quarter of FY2025, Yili delivered better-than-expected growth, achieving simultaneous increases in both revenue and net profit despite challenging market conditions. A Media Snippet accompanying this announcement is available in this link. For FY2024, Yili has proposed a dividend payout of 7.726 billion yuan, representing a record-high payout ratio of 91.4%. During the reporting period, the company also

Continue Reading

EAACI Hong Kong Allergy School 2025: A Landmark in Global Allergy Education

ZURICH, May 08, 2025 (GLOBE NEWSWIRE) — The European Academy of Allergy & Clinical Immunology (EAACI), in partnership with the Hong Kong Institute of Allergy (HKIA), is proud to announce the inaugural EAACI Hong Kong Allergy School. This significant milestone will unfold in Hong Kong – Asia’s World City – a dynamic hub where East meets West, innovation meets tradition, and global minds converge. Under the theme “East Meets West”, the 2025 edition of the Allergy School represents a bold step in fostering cross-continental collaboration in allergy and clinical immunology. By bringing together leading global experts, this flagship event aims

Continue Reading

Antalpha lance son introduction en bourse

SINGAPOUR, 07 mai 2025 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (« Antalpha » ou la « Société ») a annoncé aujourd’hui le lancement de sa tournée de présentation (roadshow), dans le cadre de son projet d’introduction en bourse portant sur 3 850 000 actions ordinaires, à un prix indicatif compris entre 11,00 $ et 13,00 $ par action. Antalpha prévoit d’accorder aux souscripteurs une option de 30 jours pour acquérir jusqu’à 577 500 actions supplémentaires, afin de couvrir d’éventuelles surallocations. La Société a déposé une demande d’inscription de ses actions ordinaires sur le Nasdaq Global Market, sous le symbole « ANTA ». Roth Capital Partners et Compass

Continue Reading